🇺🇸 Lanthanum Carbonate Chewable Tablet in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Body Temperature Decreased — 1 report (10%)
2. Chest Pain — 1 report (10%)
3. Constipation — 1 report (10%)
4. Contusion — 1 report (10%)
5. Dialysis — 1 report (10%)
6. Dyspnoea — 1 report (10%)
7. Eosinophilia — 1 report (10%)
8. Haemorrhage Subcutaneous — 1 report (10%)
9. Hepatic Neoplasm Malignant — 1 report (10%)
10. Hepatitis Cholestatic — 1 report (10%)

Source database →

Frequently asked questions

Is Lanthanum Carbonate Chewable Tablet approved in United States?

Lanthanum Carbonate Chewable Tablet does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Lanthanum Carbonate Chewable Tablet in United States?

SIGA Technologies is the originator. The local marketing authorisation holder may differ — check the official source linked above.